Document is current
Any future updates will be listed below
-
Authors
Pertziger, Eugenia https://orcid.org/0009-0004-7107-8398
Hillesheim, Elaine https://orcid.org/0000-0002-2138-3181
Bonny, Olivier https://orcid.org/0000-0003-4123-4279
Wagner, Carsten A. https://orcid.org/0000-0002-9874-8898
Vergères, Guy https://orcid.org/0000-0003-4574-0590
Bochud, Murielle https://orcid.org/0000-0002-5727-0218
Burton-Pimentel, Kathryn J. https://orcid.org/0000-0002-7314-2187
-
Funding
Funding for this research was provided by:
: Please see/use the "Funding" declaration from the manuscript
- License Information
-
More Information
Article History
Received: 30 October 2025
Accepted: 22 January 2026
First Online: 12 February 2026
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose. Carsten A. Wagner reports honoraria from Kyowa Kirin and Springer Nature and collaborations with Novo Nordisk and Bayer AG and Olivier Bonny reports honoraria from Otsuka, Alexion, Boehringer Ingelheim, CSL Vifor, and Fresenius without any link with the present study.
: The SKSC study was approved by the Cantonal Ethics Committees of all participating centres (KEK-2013-0330) and BASEC (PB_2016-01578), registered on ClinicalTrials.gov (NCT01990027) and conducted according to the Declaration of Helsinki, ICH-GCP, and Swiss law on human studies. Informed consent was obtained from all individual participants included in the study.
